BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 25972533)

  • 1. Molecular Mechanism for LAMP1 Recognition by Lassa Virus.
    Cohen-Dvashi H; Cohen N; Israeli H; Diskin R
    J Virol; 2015 Aug; 89(15):7584-92. PubMed ID: 25972533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mapping of the Lassa virus LAMP1 binding site reveals unique determinants not shared by other old world arenaviruses.
    Israeli H; Cohen-Dvashi H; Shulman A; Shimon A; Diskin R
    PLoS Pathog; 2017 Apr; 13(4):e1006337. PubMed ID: 28448640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutational Analysis of Lassa Virus Glycoprotein Highlights Regions Required for Alpha-Dystroglycan Utilization.
    Acciani M; Alston JT; Zhao G; Reynolds H; Ali AM; Xu B; Brindley MA
    J Virol; 2017 Sep; 91(18):. PubMed ID: 28679759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of LAMP1 Binding and pH Sensing by the Spike Complex of Lassa Virus.
    Cohen-Dvashi H; Israeli H; Shani O; Katz A; Diskin R
    J Virol; 2016 Nov; 90(22):10329-10338. PubMed ID: 27605678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acidic pH-Induced Conformations and LAMP1 Binding of the Lassa Virus Glycoprotein Spike.
    Li S; Sun Z; Pryce R; Parsy ML; Fehling SK; Schlie K; Siebert CA; Garten W; Bowden TA; Strecker T; Huiskonen JT
    PLoS Pathog; 2016 Feb; 12(2):e1005418. PubMed ID: 26849049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lamp1 Increases the Efficiency of Lassa Virus Infection by Promoting Fusion in Less Acidic Endosomal Compartments.
    Hulseberg CE; Fénéant L; Szymańska KM; White JM
    mBio; 2018 Jan; 9(1):. PubMed ID: 29295909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential Antibody-Based Immune Response against Isolated GP1 Receptor-Binding Domains from Lassa and Junín Viruses.
    Borenstein-Katz A; Shulman A; Hamawi H; Leitner O; Diskin R
    J Virol; 2019 Apr; 93(8):. PubMed ID: 30728269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical role for cholesterol in Lassa fever virus entry identified by a novel small molecule inhibitor targeting the viral receptor LAMP1.
    Wang MK; Ren T; Liu H; Lim SY; Lee K; Honko A; Zhou H; Dyall J; Hensley L; Gartin AK; Cunningham JM
    PLoS Pathog; 2018 Sep; 14(9):e1007322. PubMed ID: 30265711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging intracellular receptors for hemorrhagic fever viruses.
    Jae LT; Brummelkamp TR
    Trends Microbiol; 2015 Jul; 23(7):392-400. PubMed ID: 26004032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small-Molecule Fusion Inhibitors Bind the pH-Sensing Stable Signal Peptide-GP2 Subunit Interface of the Lassa Virus Envelope Glycoprotein.
    Shankar S; Whitby LR; Casquilho-Gray HE; York J; Boger DL; Nunberg JH
    J Virol; 2016 Aug; 90(15):6799-807. PubMed ID: 27194767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure and receptor recognition by the Lassa virus spike complex.
    Katz M; Weinstein J; Eilon-Ashkenazy M; Gehring K; Cohen-Dvashi H; Elad N; Fleishman SJ; Diskin R
    Nature; 2022 Mar; 603(7899):174-179. PubMed ID: 35173332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lassa virus glycoprotein: stopping a moving target.
    Hastie KM; Saphire EO
    Curr Opin Virol; 2018 Aug; 31():52-58. PubMed ID: 29843991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virus entry. Lassa virus entry requires a trigger-induced receptor switch.
    Jae LT; Raaben M; Herbert AS; Kuehne AI; Wirchnianski AS; Soh TK; Stubbs SH; Janssen H; Damme M; Saftig P; Whelan SP; Dye JM; Brummelkamp TR
    Science; 2014 Jun; 344(6191):1506-10. PubMed ID: 24970085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic diversity among Lassa virus strains.
    Bowen MD; Rollin PE; Ksiazek TG; Hustad HL; Bausch DG; Demby AH; Bajani MD; Peters CJ; Nichol ST
    J Virol; 2000 Aug; 74(15):6992-7004. PubMed ID: 10888638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis for antibody-mediated neutralization of Lassa virus.
    Hastie KM; Zandonatti MA; Kleinfelter LM; Heinrich ML; Rowland MM; Chandran K; Branco LM; Robinson JE; Garry RF; Saphire EO
    Science; 2017 Jun; 356(6341):923-928. PubMed ID: 28572385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uncoupling GP1 and GP2 expression in the Lassa virus glycoprotein complex: implications for GP1 ectodomain shedding.
    Illick MM; Branco LM; Fair JN; Illick KA; Matschiner A; Schoepp R; Garry RF; Guttieri MC
    Virol J; 2008 Dec; 5():161. PubMed ID: 19105844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acidic pH Triggers Lipid Mixing Mediated by Lassa Virus GP.
    Bulow U; Govindan R; Munro JB
    Viruses; 2020 Jul; 12(7):. PubMed ID: 32630688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidation-sensitive polymersomes as vaccine nanocarriers enhance humoral responses against Lassa virus envelope glycoprotein.
    Galan-Navarro C; Rincon-Restrepo M; Zimmer G; Ollmann Saphire E; Hubbell JA; Hirosue S; Swartz MA; Kunz S
    Virology; 2017 Dec; 512():161-171. PubMed ID: 28963882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delineating the mechanism of anti-Lassa virus GPC-A neutralizing antibodies.
    Enriquez AS; Buck TK; Li H; Norris MJ; Moon-Walker A; Zandonatti MA; Harkins SS; Robinson JE; Branco LM; Garry RF; Saphire EO; Hastie KM
    Cell Rep; 2022 May; 39(8):110841. PubMed ID: 35613585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shedding of soluble glycoprotein 1 detected during acute Lassa virus infection in human subjects.
    Branco LM; Grove JN; Moses LM; Goba A; Fullah M; Momoh M; Schoepp RJ; Bausch DG; Garry RF
    Virol J; 2010 Nov; 7():306. PubMed ID: 21062490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.